Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Mangoceuticals Inc MGRX

Healthcare Medical Care

Recent & Breaking News (NDAQ:MGRX)

Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent

GlobeNewswire 3 days ago

Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split

GlobeNewswire December 4, 2024

Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire October 31, 2024

MangoRx Announces Formation of Strategy and Alternatives Committee

GlobeNewswire October 22, 2024

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly

GlobeNewswire October 21, 2024

Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024

Newsfile October 18, 2024

MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN

GlobeNewswire October 11, 2024

MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions

GlobeNewswire October 3, 2024

MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment

GlobeNewswire October 1, 2024

MangoRx Reports 1,685% Increase in Shareholders' Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024

GlobeNewswire August 15, 2024

MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology Patent

GlobeNewswire August 13, 2024

MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and Tirzepatide

GlobeNewswire August 9, 2024

MangoRx Receives Request for Proposal (RFP) From ISFLST for New Male Enhancement Product Exclusive for the Asian Market

Accesswire August 8, 2024

MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology

GlobeNewswire July 24, 2024

Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access

GlobeNewswire July 18, 2024

MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts

GlobeNewswire July 16, 2024

MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department

GlobeNewswire July 12, 2024

MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets

GlobeNewswire July 11, 2024

MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology

GlobeNewswire June 6, 2024

MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies

GlobeNewswire June 4, 2024